Skip to main content
 

Our Invokana News

Below are some of our news stories explaining the potential dangers of Invokana, and especially the connection to kidney failure, heart attacks, and ketoacidosis. To learn more about the types of injuries that have been linked to this medication, and the legal claims that have been filed, click Invokana.

 

On December 4, 2015, the U.S. Food and Drug Administration finally updated a safety announcement, first issued the previous May,…

Janssen Pharmaceutica has allegedly been engaging in illegal marketing tactics for its diabetic medication Invokana  – and consumer advocacy organization Public Citizen has called them out on…

Invokana (canagliflozin) has been implicated in elevated risks of diabetic ketoacidosis (dangerous blood acidity), kidney failure, and more recently,…

According to data from the U.S. Centers for Medicare and Medicaid…

SGLT2 inhibitors Invokana and Farxiga, used in the treatment of Type 2 diabetes, have been targeted for a safety review by Canada's public health authority. These drugs cause excess blood sugar to…

Recently, Levin Papantonio posted an article on early concerns expressed over the…

Much of the recent bad news surrounding the new “miracle” diabetic drug Invokana (canagliflozin) has to do with a condition known as…

Drugmaker Mitsubishi Tanabe Pharma has a history going back almost 340 years, primarily resulting from a number of mergers, acquisitions and takeovers during the 20th Century.…

Invokana (canagliflozin) is the latest in a line of drugs designed to treat Type 2 (adult-onset) diabetes. Like its predecessors, glitazone (Actos, Avandia) and sitagliptin…

Subscribe to Invokana News
Customize This